ArticleAlimentary pharmacology & therapeutics2012

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis.

E Rostholder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.